Top NYC, NY Companies With Best Stability & Growth (8,366)

Strong Market Position & Advantage: Reported presence in over two‑thirds of U.S. districts and an estimated annual reach of 25 million students signal entrenched adoption in K–8 supplemental content. Ongoing district contracts and widespread classroom usage references suggest durable positioning.

Product Line Growth: Recent updates span LMS integrations via Clever, new content collections (e.g., AI Literacy), and 21 new movies in 2025 alongside continued build‑out of BrainPOP Science. This steady roadmap indicates active investment to deepen use cases and support retention.

Investor Backing & Capital Strength: KIRKBI’s 2022 acquisition and continued emphasis on BrainPOP’s “next phase of growth” provide resources and mandate to scale. Leadership appointments across 2025 were framed to accelerate innovation and district focus.

Strong Revenue Growth: Revenue is reported as nearing $100 million over the prior 12 months with triple-digit increases and billions in annual transaction activity, indicating rapid scaling. Growth in customers from roughly 40,000 to over 70,000 by mid-2025 further supports accelerating topline momentum.

Investor Backing & Capital Strength: Capital support is evidenced by a $28 million Series C that valued the company at about $510 million and total funding of roughly $70 million. These up-rounds signal investor confidence and provide resources to fund continued expansion.

Innovation-Driven Growth: Product velocity is highlighted by launches such as instant payouts, an AI marketing assistant, client waivers and deposits, and 2024 Teams features like time-tracking, payroll, and collaborative calendars. Continuous feature delivery aligns with a strategy to deepen utility and drive adoption.

Market Expansion: Recent customer launches across banks and credit unions, entry into core marketplaces, and wins at larger institutions indicate expanding reach and distribution. Public announcements highlight faster go-lives within the community bank and credit union segment alongside movement up‑market.

Product Line Growth: The launch of new modules in lending, fraud, instant payments, and a unified platform approach signal a broadening product footprint. Company updates describe continued feature velocity and AI-driven capabilities being added to the suite.

Innovation-Driven Growth: Collaborations on AI and regular release cadence point to rapid experimentation and delivery. Public case examples show novel use cases being deployed in production environments.

Investor Backing & Capital Strength: A $120M funding round announced on June 18, 2024 is highlighted as a strong proxy for expansion capacity. TechCrunch’s year-end recap lists AKASA among U.S. AI startups that raised $100M+ in 2024.

Strategic Partnerships: Cleveland Clinic rolled out AKASA’s AI coding tools systemwide in early 2025 and expanded to a CDI solution across all U.S. locations by October 13, 2025. An Oracle Cerner collaboration broadens access to AKASA’s automation for EHR customers.

Market Expansion: AKASA’s site states its client base represents 650+ hospitals and 6,500+ outpatient facilities across all 50 states. Named customer outcomes such as Nebraska Methodist’s reported $2M+ gross revenue lift and the upsell within Cleveland Clinic indicate footprint growth and upsell potential.

Investor Backing & Capital Strength: Public reports describe a June 2025 Series B led by TELUS Global Ventures that materially increased funding and enabled expansion. This level of backing is presented as a key enabler for scaling the platform.

Strong Market Position & Advantage: New 2025–2026 enterprise case studies with well-known brands and references to a large set of forward‑thinking clients point to ongoing wins and account expansion. Distribution of the 2026 forecast via an industry publication suggests growing market credibility.

Strategic Partnerships: TELUS references a 2025 commercial partnership integrating the platform into go‑to‑market efforts. This corroborates that large strategics are embedding the product within broader workflows.

Investor Backing & Capital Strength: Spark announced a significant Series B financing following its prior round at a higher valuation, signaling strong investor confidence. This provides fresh capital to fund product development, hiring, and go-to-market efforts.

Market Expansion: Public materials describe a rapidly growing broker base, materially higher enrollments by 2025, and nationwide licensing, indicating broader market reach. Active hiring and open roles further suggest continued scaling across geographies and channels.

Innovation-Driven Growth: Ongoing platform updates, AI-enabled workflows, and regular Medicare/CMS analyses point to sustained product investment. These enhancements are positioned to increase agent productivity and platform throughput over time.

Strong Revenue Growth: Reported 31% year‑over‑year revenue growth to about $2.2 billion in 2025, alongside higher margins, with guidance of $2.63–$2.67 billion for 2026 and multiple indications of raised outlooks post‑IPO.

Diversified Revenue Streams: Disclosures highlight rising contributions from platform-related products such as MyPay (scaling to a $400M+ annualized run rate), Instant Loans, and Outbound Instant Transfer, adding to interchange-driven payments revenue.

Strong Market Position & Advantage: Multiple sources describe Chime as the leading U.S. neobank by active users, with J.D. Power data showing the highest share of new checking account openings in late 2025 and continued brand momentum after its June 2025 IPO.

Product Line Growth: The company launched a unified platform and introduced new solutions (e.g., a sports marketing offering), while acquisitions like Playground xyz expanded into attention measurement and optimization. Materials also describe strong year-over-year momentum for its core contextual product following these rollouts.

Strategic Partnerships: Availability through major buying pipes (e.g., Xandr) and a global video partnership with ShowHeroes expanded addressable inventory and demand. Additional ecosystem ties with major DSPs are cited as broadening reach and access.

Market Expansion: Geographic footprint widened via acquisitions and integration across Europe and APAC, with leaders calling Australia a real growth market. New channels and formats, including premium video/CTV and in‑video opportunities, further extend commercial reach.

Investor Backing & Capital Strength: Feedback suggests a $30M Series A in 2022 led by Optum Ventures with participation from Cigna Ventures provides meaningful runway for execution. This capital underpins the pivot and subsequent product buildout.

Future-Ready Strategy: After divesting its TPA unit in October 2023, the company refocused on a healthcare data/AI platform (Relay) with enterprise-grade controls (SOC 2 Type II, HIPAA alignment, HITRUST), targeting payer/TPA needs. This sharpened software focus typically supports more scalable, higher‑margin growth.

Product Line Growth: The launch of the Relay integration platform (March 2023) and expanded modules/use cases on the site/docs indicate continued product development. Recent case studies and content, alongside selective hiring, suggest active build-and-sell motion.

Strong Revenue Growth: Full‑year 2025 sales rose 8% to $11.68B with Q4 up 12% year over year. Management guided 2026 revenue to about $12.7B, indicating continued growth.

Healthy Cash Flow: Operating cash flow reached a record $2.8B in 2025, up 19% year over year. Strong cash generation accompanied record earnings and backlog.

Future-Ready Strategy: Higher‑margin, recurring Software & Services grew 13% in 2025 and the portfolio was broadened by acquisitions in MANET wireless and cloud‑native 911. A record $15.7B backlog and a 2026 EPS outlook of $16.70–$16.85 point to multi‑year momentum.

Strong Revenue Growth: Reported results show double-digit year-over-year net sales increases with multi‑year momentum and consistent quarterly execution. Management also guides to further top‑line growth in the upcoming year, reinforcing the trajectory.

Profitability: Disclosures indicate rising net income and adjusted EBITDA alongside gross‑margin expansion driven by cost optimization and mix benefits. Recent quarter margins improved as operating leverage increased.

Market Expansion: Operations show growth across both domestic and international markets, with international expansion outpacing domestic gains. Management highlights continued global scaling supported by broader retail reach and category entries.

Market Expansion: Public materials indicate the network scaled from over 2,500 community sites in 2023 to 6,000+ research sites and 25+ sponsors across 50+ countries by April 2026. This sequential ramp across sites, sponsors, and geographies suggests continued expansion on both sides of the marketplace.

Strategic Partnerships: New and expanding collaborations—such as AbbVie oncology rollouts and integrations with RealTime eClinical Solutions and CRIO—point to growing demand-side traction and data connectivity. These relationships embed the platform into sponsor and site workflows, reinforcing usage and reach.

Innovation-Driven Growth: The company launched AI Site Selection and AI-powered patient pre-screening in 2025, with 2026 case posts highlighting time and cost savings on active studies. This product velocity and real-world application signal ongoing innovation tied to operational outcomes.

Strong Revenue Growth: Media, Studios, and Theme Parks posted strong year-over-year gains, with underlying Media growth remaining solid even when excluding major events. Peacock also scaled revenue alongside an increase in paid subscribers, contributing to overall top-line momentum.

Diversified Revenue Streams: Multiple engines—theme parks (boosted by Epic Universe), studios, live sports/advertising, and Peacock—are each adding to growth. Record Upfront commitments and international networks strength further spread revenue across segments.

Strong Market Position & Advantage: Record Upfront ad sales and strong demand for live sports inventory signal robust advertiser pull. Marquee rights across the Olympics and the NBA, combined with Peacock’s ad-supported reach, reinforce competitive positioning.

Strong Market Position & Advantage: Industry recognition (e.g., 2025 Forbes Cloud 100) and reports of tens of millions of daily users signal broad adoption and durable category presence. Significant enterprise adoption gains into 2026 reinforce traction in B2B.

Investor Backing & Capital Strength: A $1B growth financing in May 2025 provides substantial runway to invest in product and go‑to‑market. Independent ARR estimates around 2025 further indicate capacity to fund expansion.

Product Line Growth: Acquisitions of Coda and the Superhuman email client, plus the launch of Superhuman Go working across 100+ apps, expanded scope beyond writing assistance. This broader suite increases cross‑sell potential and the overall addressable surface.

Investor Backing & Capital Strength: Public signals indicate strong investor confidence, including a 2022 Series D at a unicorn valuation and a 2025 definitive agreement to be acquired by STG. Feedback suggests this capital support underpins continued scaling and product investment.

Innovation-Driven Growth: The company continues to ship AI-driven product enhancements and expand availability (e.g., Da Vinci and Studio) with active customer case studies into 2025–2026. Feedback suggests sustained product velocity is driving adoption and performance gains.

Profitability: Company communications describe the business as profitable with high net retention. Such fundamentals indicate a durable base for reinvestment and stability.

Strong Revenue Growth: In December 2024, leadership indicated the company was on track for about $350M on its “contribution” metric, up from roughly $140M in 2022. Platform throughput also expanded in 2024 with $27B+ in payroll processed, $7.9B in taxes, and 245k+ W‑2s.

Market Expansion: The launch of Employer of Record for Canada in 2024 and scaling of international EOR broadened the company’s reach beyond its U.S. PEO core. Serving 12,000+ small businesses as of 2024/2025 aligns with an expanding footprint.

Product Line Growth: The company introduced a standalone Payroll product in 2023 and continued to add capabilities, including an Analytics feature in 2026. These additions signal ongoing platform enhancement and a wider offering set.

Investor Backing & Capital Strength: A Tiger Global–led $50M Series B in late 2022, alongside earlier rounds, provides resources to scale product and go‑to‑market through the mid‑2020s. Participation from firms such as Workday Ventures underscores confidence in enterprise expansion potential.

Strategic Partnerships: Ecosystem moves like the 2025 partnership with Intecrowd to accelerate Workday deployments and NetSuite‑focused partners expand reach into large enterprise platforms. These alliances align the channel for mid‑market and enterprise growth.

Innovation-Driven Growth: A steady cadence of AI‑powered launches (e.g., Fall 2024 Projects and Advanced Mapping) and the ChatCSV acquisition indicate sustained R&D aimed at enterprise data migration. The late‑2025 rebrand to Obvious while keeping Flatfile as the product broadens AI‑assisted collaboration scope.

Investor Backing & Capital Strength: Feedback suggests Canoe secured fresh capital in a Series C led by Goldman Sachs alongside independent coverage noting a step-up in valuation and continued adoption. This funding is directed toward scaling AI infrastructure and operations, indicating balance-sheet support for expansion.

Market Expansion: Feedback suggests Canoe reports record growth in EMEA with over 100 organizations and a larger London office and team, alongside new clients across APAC. Operations now span multiple countries and U.S. states, signaling a broader geographic footprint.

Strategic Partnerships: Feedback suggests integrations deepened in 2025–2026, including Prime Buchholz expanding its Canoe integration and a certified delivery of private fund data into Bloomberg PORT Enterprise. These ties indicate growing embedment in downstream analytics and reporting workflows.

Strong Revenue Growth: Recent disclosures show revenue and originations advancing across 2025 and into early 2026, with record receivables underpinning a higher run-rate. Quarterly updates indicate continued top-line momentum across both consumer and small-business lending.

Profitability: Unit economics appear stable to improving, with net revenue margins holding firm and earnings measures increasing alongside scale. Adjusted EBITDA expanded year over year, reflecting solid conversion of revenue to profit.

Future-Ready Strategy: Management is pursuing the Grasshopper Bank acquisition to add a bank charter and diversify funding, which could support longer-term growth. Expansion moves and an analytics-led underwriting platform position the business to scale.

Strong Revenue Growth: Record quarterly and full-year trading revenues in 2024–2025 signal accelerating top-line momentum. A record first quarter in 2025 and a record first half despite a softer Q2 point to sustained growth.

Profitability: Reported profits reached new highs alongside the revenue gains, including a record Q1 2025. Expanded margins and sizable EBITDA underscore strong earnings power.

Product Line Growth: The launch of High Touch Equities and expansion into processing fixed-income trades for smaller banks indicate broadening services. New offerings across rates, options, credit, and block trading show diversification beyond pure electronic market making.